361 Universal expansion of CBL-B-inhibited tumor infiltrating lymphocytes, DeTIL-0255, from women with ovarian cancer: Process validation

Pranav Murthy; Nell Namitha Narasappa; Xiaoyan Liang; Xianzhu Wu; Irene Luu; Jeevitha Jeevan; Sagar Sharma; Alison Ross; Caleb Lampenfeld; Sam Zahn; Thomas Musial; Jennifer Bone; John Nakayama; David Bartlett; Jocelyn Chapman; Greta Garrido; Nicholas Shinners; Arthur Sands; Michael Blackton; Ena Wang; Michael Lotze

doi:10.1136/jitc-2022-SITC2022.0361

Article info

Regular and Young Investigator Award Abstracts

Cell Therapies

361 Universal expansion of CBL-B-inhibited tumor infiltrating lymphocytes, DeTIL-0255, from women with ovarian cancer: Process validation

Free

Authors

Pranav Murthy Nurix Therapeutics, San Francisco, CA, USA PubMed articles Google scholar articles
Nell Namitha Narasappa Nurix Therapeutics, San Francisco, CA, USA PubMed articles Google scholar articles
Xiaoyan Liang Nurix Therapeutics, San Francisco, CA, USA PubMed articles Google scholar articles
Xianzhu Wu Nurix Therapeutics, San Francisco, CA, USA PubMed articles Google scholar articles
Irene Luu Nurix Therapeutics, San Francisco, CA, USA PubMed articles Google scholar articles
Jeevitha Jeevan Nurix Therapeutics, San Francisco, CA, USA PubMed articles Google scholar articles
Sagar Sharma Nurix Therapeutics, San Francisco, CA, USA PubMed articles Google scholar articles
Alison Ross Nurix Therapeutics, San Francisco, CA, USA PubMed articles Google scholar articles
Caleb Lampenfeld Nurix Therapeutics, San Francisco, CA, USA PubMed articles Google scholar articles
Sam Zahn Nurix Therapeutics, San Francisco, CA, USA PubMed articles Google scholar articles
Thomas Musial Nurix Therapeutics, San Francisco, CA, USA PubMed articles Google scholar articles
Jennifer Bone Nurix Therapeutics, San Francisco, CA, USA PubMed articles Google scholar articles
John Nakayama Allegheny Health Network, Pittsburgh, PA, USA PubMed articles Google scholar articles
David Bartlett Allegheny Health Network, Pittsburgh, PA, USA PubMed articles Google scholar articles
Jocelyn Chapman UCSF Medical Center, San Francisco, CA, USA PubMed articles Google scholar articles
Greta Garrido Nurix Therapeutics, San Francisco, CA, USA PubMed articles Google scholar articles
Nicholas Shinners Nurix Therapeutics, San Francisco, CA, USA PubMed articles Google scholar articles
Arthur Sands Nurix Therapeutics, San Francisco, CA, USA PubMed articles Google scholar articles
Michael Blackton Nurix Therapeutics, San Francisco, CA, USA PubMed articles Google scholar articles
Ena Wang Nurix Therapeutics, San Francisco, CA, USA PubMed articles Google scholar articles
Michael Lotze Nurix Therapeutics, San Francisco, CA, USA PubMed articles Google scholar articles

Citation

Murthy P, Narasappa NN, Liang X, et al

361 Universal expansion of CBL-B-inhibited tumor infiltrating lymphocytes, DeTIL-0255, from women with ovarian cancer: Process validation

Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.0361

Publication history

First published November 7, 2022.

Online issue publication

April 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password